TO: ALL CURRENT HOLDERS OF AVIS BUDGET GROUP, INC. (“AVIS” OR THE “COMPANY”) SHARES OF COMMON STOCK GlobeNewswire February 27, 2026 SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) — PLEASE READ THIS NOTICE CAREFULLY AND COMPLETELY. YOUR RIGHTS MAY BE AFFECTED. THIS NOTICE RELATES TO A PROPOSED VOLUNTARY DISMISSAL OF A SHAREHOLDER DERIVATIVE ACTION AND […]
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Smart Digital Group Limited ("Smart Digital", "SDM" or the "Company") (NASDAQ:SDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. ("Agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Picard Medical, Inc. ("Picard" or the "Company") (NYSE:PMI).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ostin Technology Group Co., Ltd. ("Ostin" or the "Company") (NASDAQ:OST).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE:KD).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fermi Inc. ("Fermi" or the "Company") (NASDAQ:FRMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against AMC Entertainment Holdings, Inc. ("AMC" or the "Company") (NYSE:AMC;APE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against PayPal Holdings, Inc. ("PayPal" or the "Company") (NASDAQ:PYPL).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against REGENXBIO Inc. ("Regenxbio" or the "Company") (NASDAQ:RGNX).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged